EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy

Erik Thunnissen, Judith V. M. G. Bovee, Hans Bruinsma, Adriaan J. C. van den Brule, Winand N. M. Dinjens, Danielle A. M. Heideman, Els Meulemans, Petra Nederlof, Carel van Noesel, Clemens F. M. Prinsen, Karen Scheidel, Peter M. van de Ven, Roel A. de Weger, Ed Schuuring, Marjolijn J. L. Ligtenberg

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)884-892
JournalJournal of Clinical Pathology
Volume64
Issue number10
DOIs
Publication statusPublished - Oct 2011

Cite this

Thunnissen, E., Bovee, J. V. M. G., Bruinsma, H., van den Brule, A. J. C., Dinjens, W. N. M., Heideman, D. A. M., Meulemans, E., Nederlof, P., van Noesel, C., Prinsen, C. F. M., Scheidel, K., van de Ven, P. M., de Weger, R. A., Schuuring, E., & Ligtenberg, M. J. L. (2011). EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy. Journal of Clinical Pathology, 64(10), 884-892. https://doi.org/10.1136/jclinpath-2011-200163